Medicamen Biotech Limited — Others, 20-03-2025: Corrigendum

Medicamen Biotech Limited has issued a corrigendum to the notice for its Extra-Ordinary General Meeting (EGM) set for March 26, 2025. This corrigendum brings attention to changes in the explanatory statements for agenda items 1 and 2. Specifically, it updates the objects of the preferential issue, clarifying: the deletion of "etc." in the registration of dossiers; the removal of "in some area of upgradation" regarding capital expenditure; and the elimination of a subpoint about participation in domestic medical conferences. The respective headings in the Utilization of Proceeds table now reflect these changes. All other details from the original EGM notice remain unchanged. Shareholders are encouraged to review the updated information, available on the company’s website and stock exchange platforms.